STOK (Stoke Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Stoke Therapeutics, Inc. Common Stock (STOK) is a publicly traded Healthcare sector company. As of May 21, 2026, STOK trades at $30.76 with a market cap of $1.81B and a P/E ratio of -10.54. STOK moved +1.13% today. Year to date, STOK is -6.93%; over the trailing twelve months it is +201.44%. Its 52-week range spans $5.35 to $40.22. Analyst consensus is strong buy with an average price target of $46.71. Rallies surfaces STOK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading STOK stock inside the company?

Recent STOK insider activity includes Ticho Barry sold 2.24K, Ticho Barry sold 1.84K, Allan Jonathan sold 8.69K, Allan Jonathan sold 601, and Ticho Barry sold 1.46K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

STOK Key Metrics

Key financial metrics for STOK
MetricValue
Price$30.76
Market Cap$1.81B
P/E Ratio-10.54
EPS$-2.84
Dividend Yield0.00%
52-Week High$40.22
52-Week Low$5.35
Volume506.93K
Avg Volume0
Revenue (TTM)$32.08M
Net Income$-169.77M
Gross Margin0.00%

Recent STOK Insider Trades

  • Ticho Barry sold 2.24K (~$73.55K) on May 1, 2026.
  • Ticho Barry sold 1.84K (~$60.03K) on Apr 1, 2026.
  • Allan Jonathan sold 8.69K (~$292.36K) on Mar 20, 2026.
  • Allan Jonathan sold 601 (~$20.68K) on Mar 20, 2026.
  • Ticho Barry sold 1.46K (~$43.82K) on Mar 19, 2026.

STOK Analyst Consensus

8 analysts cover STOK: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $46.71.

Common questions about STOK

Who is trading STOK stock inside the company?
Recent STOK insider activity includes Ticho Barry sold 2.24K, Ticho Barry sold 1.84K, Allan Jonathan sold 8.69K, Allan Jonathan sold 601, and Ticho Barry sold 1.46K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for STOK?
Yes. Rallies tracks STOK insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is STOK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for STOK. It does not provide personalized investment advice.
STOK

STOK